Trademark Alertz ®
Search
Trademark
Owner
Trademark: PRECISION BIOSCIENCES 2277302
Word
PRECISION BIOSCIENCES
Device Descrption:
LINKS DIVIDE DISC
ID
2277302
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
18 November 2021
Registration Date
18 November 2021
Renewal Date
18 November 2031
Owner(s)
Precision BioSciences, Inc.
Service
Goods and Services:
Class 1
:
Genome editing reagents
;
chemical, biochemical, biotechnological products intended for industry, agriculture, horticulture, namely polypeptides for in vivo and in vitro genetic engineering, natural and engineered meganucleases and endonucleases, nucleic acid vectors, molecular scissors
;
chemical, biochemical, biotechnological and bacteriological products intended for research laboratories and control laboratories, namely polypeptides for in vivo and in vitro genetic engineering
;
biochemicals and biologics, namely, engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, pharmaceutical research, agricultural biotechnology, diagnostics, and industrial biotechnology
;
engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy
;
biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research and analysis and diagnostics.
Class 42
:
Research in the fields of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic disease, gene therapy and cell therapy
;
research in genetic fields
;
research in chemistry, biology, biochemistry, molecular biology, bacteriology
;
scientific analysis.
Class 44
:
Cellular immunotherapy programs utilizing chimeric antigen receptor t cells for use in treating disease, namely, the treatment of cancer
;
cell-based immunotherapeutic treatment by way of genetically modified cells for use in human therapeutics and the treatment of cancer.